ANAVEX LIFE SCIENCES CORP. - 10-Q Filing
Anavex Life Sciences reported a Q2 net loss of $5.3M and cash balance increased to $127.4M as of March 31, 2026
Tickers: $AVXL
More Regulatory news
- Solana Co - 10-Q Filing
- Solana Co - 8-K Filing
- DeFi Development Corp. - 8-K Filing
- Stablecoin Development Corp - 8-K Filing
- BCP Investment Corp - 8-K Filing
- OneWater Marine Inc. - 8-K Filing
- Moleculin Biotech, Inc. - 8-K Filing
- Investcorp Credit Management BDC, Inc. - 8-K Filing
- Presurance Holdings, Inc. - 10-Q Filing
- Corteva, Inc. - 8-K Filing